Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
132 GBX | -0.38% | -0.75% | +51.72% |
May. 28 | Sirius Real Estate Non-Exec Director James Peggie to resign | AN |
May. 24 | Michael Ashcroft ups stake in Marlowe to 16% | AN |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Capitalization 1 | 70.97 | 112.2 | 85.75 | 63.68 | 111.4 | 111.4 | - |
Enterprise Value (EV) 1 | 59.25 | 87.1 | 66.08 | 43.84 | 73.32 | 97.71 | 96.25 |
P/E ratio | 165 x | 393 x | - | 89.9 x | -42 x | -64.1 x | 95.7 x |
Yield | - | - | - | - | - | - | - |
Capitalization / Revenue | 5.3 x | 8.84 x | 6.15 x | 3.26 x | 3.09 x | 3.77 x | 2.96 x |
EV / Revenue | 4.42 x | 6.86 x | 4.74 x | 2.25 x | 3.09 x | 3.31 x | 2.56 x |
EV / EBITDA | 24.7 x | 162 x | 28.1 x | 12.2 x | 31.1 x | 35 x | 14.1 x |
EV / FCF | - | - | -13.1 x | 194 x | -24.3 x | -28.1 x | 69.8 x |
FCF Yield | - | - | -7.61% | 0.52% | -4.11% | -3.56% | 1.43% |
Price to Book | - | - | - | 1.53 x | 2.71 x | 2.91 x | 2.76 x |
Nbr of stocks (in thousands) | 69,583 | 84,069 | 84,069 | 84,339 | 84,427 | 84,427 | - |
Reference price 2 | 1.020 | 1.335 | 1.020 | 0.7550 | 1.325 | 1.325 | 1.325 |
Announcement Date | 3/16/20 | 3/15/21 | 3/22/22 | 4/17/23 | 5/21/24 | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Net sales 1 | 13.4 | 12.7 | 13.94 | 19.5 | 23.7 | 29.54 | 37.6 |
EBITDA 1 | 2.4 | 0.539 | 2.349 | 3.583 | 2.357 | 2.79 | 6.816 |
EBIT 1 | 0.7404 | -0.658 | 0.55 | 0.574 | -3.018 | -2.493 | 1.335 |
Operating Margin | 5.53% | -5.18% | 3.94% | 2.94% | -12.73% | -8.44% | 3.55% |
Earnings before Tax (EBT) 1 | 0.4973 | -0.682 | - | 0.564 | -2.438 | -2.271 | 1.358 |
Net income 1 | 0.3979 | 0.263 | 0.561 | 0.724 | -1.746 | -2.215 | 0.692 |
Net margin | 2.97% | 2.07% | 4.02% | 3.71% | -7.37% | -7.5% | 1.84% |
EPS 2 | 0.006200 | 0.003400 | - | 0.008400 | -0.0207 | -0.0207 | 0.0138 |
Free Cash Flow 1 | - | - | -5.031 | 0.226 | -3.92 | -3.475 | 1.379 |
FCF margin | - | - | -36.08% | 1.16% | -16.45% | -11.76% | 3.67% |
FCF Conversion (EBITDA) | - | - | - | 6.31% | - | - | 20.23% |
FCF Conversion (Net income) | - | - | - | 31.22% | - | - | 199.29% |
Dividend per Share 2 | - | - | - | - | - | - | - |
Announcement Date | 3/16/20 | 3/15/21 | 3/22/22 | 4/17/23 | 5/21/24 | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 S1 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 |
---|---|---|---|---|---|---|---|
Net sales 1 | - | - | 11.98 | 9.924 | 13.78 | 11.9 | 17.5 |
EBITDA 1 | - | - | 3.31 | -0.232 | 2.589 | 0.1 | 2.7 |
EBIT 1 | - | - | 1.637 | -2.166 | -0.852 | -2.5 | 0.2 |
Operating Margin | - | - | 13.67% | -21.83% | -6.19% | -21.01% | 1.14% |
Earnings before Tax (EBT) 1 | - | - | 1.695 | -1.955 | -0.483 | -2.4 | 0.2 |
Net income 1 | -0.335 | -0.767 | 1.491 | -1.485 | -0.261 | -2.2 | 0.4 |
Net margin | - | - | 12.45% | -14.96% | -1.89% | -18.49% | 2.29% |
EPS 2 | -0.004000 | -0.009100 | 0.0173 | -0.0176 | -0.003100 | -0.0257 | 0.005100 |
Dividend per Share | - | - | - | - | - | - | - |
Announcement Date | 9/14/21 | 9/27/22 | 4/17/23 | 9/26/23 | 5/21/24 | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - | - |
Net Cash position 1 | 11.7 | 25.1 | 19.7 | 19.8 | 16 | 13.7 | 15.2 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
Free Cash Flow 1 | - | - | -5.03 | 0.23 | -3.92 | -3.47 | 1.38 |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - |
Book Value Per Share 2 | - | - | - | 0.4900 | 0.4900 | 0.4600 | 0.4800 |
Cash Flow per Share | - | - | - | - | - | - | - |
Capex 1 | 2.93 | 6.29 | 5.6 | 4.87 | 6.1 | 5.57 | 5.57 |
Capex / Sales | 21.84% | 49.57% | 40.17% | 24.97% | 25.6% | 18.85% | 14.81% |
Announcement Date | 3/16/20 | 3/15/21 | 3/22/22 | 4/17/23 | 5/21/24 | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+51.72% | 143M | |
+13.11% | 4.29B | |
+29.78% | 1.94B | |
-12.50% | 1.58B | |
-23.97% | 1.48B | |
-5.24% | 1.44B | |
-28.92% | 1.26B | |
-14.33% | 1.09B | |
-9.59% | 993M | |
+118.67% | 692M |
- Stock Market
- Equities
- DXRX Stock
- Financials Diaceutics PLC